VTGN
VistaGen Therapeutics Inc
0.3684$
+46.5%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -9.5% | +2.6% | +47.0% | +13.0% | +13.0% | +14.1% | +504.7% | -25.3% | +6.9% | +11.8% | +15.4% | |
| – | +64.3% | -78.9% | +175.4% | +46.9% | +11.0% | -39.6% | +50.9% | -4.1% | -34.6% | +97.8% | -7.4% | |
| – | +1,620.1% | -91.5% | +21.3% | -18.3% | +6.6% | -39.6% | +50.9% | – | – | – | – | |
| – | -124.5% | – | – | +155.3% | -90.7% | +2,044.1% | -155.8% | – | -60.9% | +500.3% | -119.7% | |
| – | +0.0% | +809.1% | -99.3% | +10,775.0% | +58.3% | +0.0% | -27.2% | +5.8% | -71.2% | +213.1% | -20.9% | |
| – | +0.0% | +809.1% | -99.3% | +10,775.0% | +58.3% | +0.0% | -27.2% | +269.4% | -91.8% | +21,454.1% | -93.3% | |
| – | – | – | -18.0% | +10.6% | +10.9% | +9.7% | -31.8% | -8.3% | – | – | – | |
| – | +68.6% | +23,591.1% | -83.7% | +455.0% | +10.9% | +9.7% | -31.8% | -100.0% | – | – | – | |
| – | -62.5% | +63.1% | +11.9% | +8.7% | +32.9% | +28.8% | -99.2% | +34,366.7% | -4.7% | -100.0% | – | |
| – | +82.9% | +92.4% | +65.3% | +5.5% | -77.0% | +2,744.2% | -90.8% | -109.9% | – | -97.5% | +864.8% | |
| – | +412.1% | +595.3% | +199.1% | -63.5% | -531.5% | – | -134.4% | – | – | -150.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.